Uehara M, Nakamura Y, Suzuki T, Takahashi J, Kato H. Efficacy of denosumab therapy after alendronate treatment for a 66-year-old woman with Camurati-Engelmann disease and osteoporosis: a case report. Modern Rheumatology. 2019
Uehara M, Nakamura Y, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, Kosho T, Kato H. Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report. Ther Clin Risk Manag. 2019. 25. 15. 303-307
Suzuki T, Nakamura Y, Kato H. Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis. Ther Clin Risk Manag. 2018. 18. 15. 15-22
Identification and Molecular Analysis of a Potential Disease-causing Mutation in ZMAT2 in Congenital Radioulnar Synostosis.
Compliance, Adverse Effects, Bone-related Mineral and Vitamin D Status, and Literature Review of Denosumab Therapy for Osteoporosis in Japan.
(American Society for Bone and Mineral Research 2018 Annual Meeting, Monyreal, 2018)